Format

Send to

Choose Destination
Lung India. 2020 Jan-Feb;37(1):77-78. doi: 10.4103/lungindia.lungindia_291_19.

Osimertinib as an emerging therapeutic modality in nonsmall cell lung cancer: Opportunities and challenges in Indian scenario.

Author information

1
Department of Pharmacology, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India.
2
Department of Pharmacology, RG Kar Medical College, Kolkata, West Bengal, India.
3
Department of Pharmacology, Burdwan Medical College, Burdwan, West Bengal, India.

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center